Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 September 2020 | Story Leonie Bolleurs | Photo Unsplash
Kidnapping and human trafficking are a real threat to people worldwide. Should you find yourself in such a situation, your main focus must be on your own safety and survival.

Kidnapping and human trafficking are a real threat to people worldwide, and recent incidents reported on social media highlight the need for staff and students to remain vigilant, says Cobus van Jaarsveld, Assistant Director: Threat Detection, Investigations and Liaison from Protection Services at the University of the Free State.

Van Jaarsveld adds that should you find yourself in such a situation, your main focus must be on your own safety and survival. 

He provides some tips to avoid being kidnapped, as well as some actions to take when you are kidnapped. These tips come from sources that deal with incidents such as these on a daily basis, including WorldAware, the South African Police Service, and Interpol.

When walking to your destination, keep the following in mind:

• Be aware of your surroundings at all times.
• Tell a trusted person where you will be, who you will be with, and when you expect to return.
• If you sense that someone is following you when you get off a bus, taxi or train, walk towards a well-populated area.
• Do not wear headphones or read while walking or standing on the street.
• When on the street, walk facing oncoming traffic. It will be harder for someone in a vehicle to abduct you.
• Do not hitchhike.
• Try to maintain a low profile.
• Modify your fashion style, toning down colours and accessories.
• Wear comfortable clothing; women should avoid wearing high heels and slippers, which are difficult to run in when attempting to escape. If you are going out with high heels, always have a pair of comfortable flat shoes handy.
• Avoid wearing clothing with long straps such as scarves, necklaces, and purses. These items can be used to strangle you or to tie you up.
• Try to not overload yourself with packages.
• Stay off the street if you are alone and upset or under the influence of medications or alcohol.
• Avoid using outside ATMs at night or in unfamiliar surroundings.
• Avoid isolated or poorly lit restrooms and be extra careful on stairwells.
• Do not get into an elevator with someone who makes you feel uncomfortable. If this is unavoidable, stand near the controls and locate the emergency button.

Prof Beatri Kruger, Research fellow at the Free State Centre for Human Rights in the UFS Faculty of Law, has conducted extensive research on the topic of human trafficking over the years. She adds to Van Jaarsveld’s safety tips and says it is important to memorise emergency telephone numbers. “Save them on your cellphone, especially the 0800 222 777 number, which is the Human Trafficking national helpline available 24/7 free of charge.”

Alternatively call the mobile phone emergency number 112 or Protection Services toll free line 080 020 4682.

“It is also important to arrange a code word with family or close friends – so that when you say or text that word and where you are, they will know to immediately come to you.”

In this day and age, Prof Kruger also urges everyone to empower themselves with reliable information on what trafficking is and what methods traffickers use to lure, deceive, trap, and control you. She suggests the website of the national Freedom Network: http://www.nationalfreedomnetwork.co.za/ or their Facebook page: https://www.facebook.com/NationalFreedomNetwork/ for more information. 

• Distribution of fake news 
 
Staff and students are requested to refrain from distributing fake news on any communication platform, as the distribution of fake news places an additional burden on the limited capacity of law enforcement agencies. 
 
Currently, a message is being distributed on social media and via WhatsApp, containing content with unconfirmed allegations that was originally distributed in 2017 (a company by the name of Forex, kidnapping females for human trafficking and selling their body parts). 
 
Protection Services supports the university's sentiment – as communicated in the Strategic Plan – that the well-being and safety of its staff and students need to receive top priority.   
 
They are currently looking into an alleged incident that occurred on 14 September 2020; all steps are being taken to ensure the safety of our students and staff. 

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept